Active Ingredient: Butylscopolamine
Dosage: 10 mg
Route of Administration: Oral
Dosage Form: Tablets
Quantity per package: 10 pills
Availability: Out of stock
Butilhioscina is a medication used to relieve abdominal pain, esophageal spasms, renal colic, and bladder spasms. It is also used to enhance respiratory secretions at the end of life.
Butilhioscina is out of stock today but you can find an alternative to this product here.
- Irritable colon in which another treatment has failed;
- Spasmodic pathologies of the biliary tract;
- Urinary diseases;
- Dysmenorrhea or nocturnal enuresis;
- As an adjuvant to anesthesia (parenteral) to prevent salivation and excessive secretions from the respiratory tract, or to produce amnesia and reduce arousal;
- Prophylaxis of arrhythmias caused by surgery or suxamethonium;
- Treatment and prophylaxis of motion sickness.
Dosage and administration
Tablets are taken orally. Take 0.25 to 0.8mg one hour before requiring the antiemetic effect. Antiemetic (parenteral) and antimuscarinic (parenteral) 0.3 to 0.6g in a single dose; children, 0.006mg / kg body weight. Anesthesia adjuvant: a) sedation-hypnosis: 0.6mg three or four times a day; b) amnesia: 0.32 to 0.65mg. Prophylaxis of salivation and excessive respiratory tract secretions in anesthesia: children: (4 to 7 months) 0.1mg; (7 months to 3 years) 0.15mg; (3 to 8 years) 0.2mg; (8 to 12 years old) 0.3mg. Transdermal forms of use as antivertiginous and antiemetic: 0.5mg that are released within three days.
Hypersensitivity to belladonna derivatives (there may be a cross-reaction).
Butilhioscina can cause drowsiness, lack of feeling of well-being, memory loss, sleep disturbances, confusion, dizziness, feeling faint, eye pain.
Signs: severe tiredness, blurred vision, clumsiness and instability, confusion, shortness of breath, dizziness, severe drowsiness, fever, tachycardia, hallucinations, seizures, dry mouth, nose and pronounced throat.
Treatment: adsorbent carbon, gastric emptying. Slow administration of neostigmine or physostigmine (to reverse antimuscarinic symptoms), short-acting barbiturates or benzodiazepines (to control delirium and excitement). Symptomatic therapy.
Butilhioscina can interact with glucocorticoids, corticotrophins, haloperidol (increased intraocular pressure), urinary alkalinizers, amantadine, tricyclic antidepressants, antihistamines, antimuscarinics, buclizine, cyclizine, cyclobenzaprine, disopyramide, ipratropium, loxapine, meclothiazine, phenothiazine, orphenadrine, inorganic acid, procainamide, thioxanthenes, antacids, antidiarrheals, antimyasthenics, cyclopropane, guanadrel, guanethidine, reserpine, ketoconazole, metoclopramide, MAOI, opioids, apomorphine, CNS depressants, parenteral lorazepam.